Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Uterine Cervical Neoplasms × Tamoxifen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 227 Carcinoma, Intraductal, Noninfiltrating 20 Breast Carcinoma In Situ 17 Neoplasm Metastasis 12 Neoplasms 11 Breast Neoplasms, Male 11 Ovarian Neoplasms 8 Inflammatory Breast Neoplasms 6 Glioblastoma 5 Endometrial Neoplasms 4 Central Nervous System Neoplasms 4 Breast Cancer Female 4 Prostatic Neoplasms 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Ductal, Breast 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Glioma 2 Fibroadenoma 2 ER+ Breast Cancer 2 Carcinoma, Lobular 2 Astrocytoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Sleep Wake Disorders 1

Interventions

Cisplatin 154 Radiotherapy 67 Paclitaxel 63 Brachytherapy 63 Carboplatin 59 pembrolizumab 57 Bevacizumab 36 Gemcitabine 27 Radiation 26 Topotecan 25 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 21 Colposcopy 21 Nivolumab 19 human papillomavirus vaccine, L1 type 16, 18 18 Platinum 18 Magnetic Resonance Spectroscopy 18 Papillomavirus Vaccines 17 Drug Therapy 15 Docetaxel 15 Cyclophosphamide 15 Biopsy 15 1,2-diaminocyclohexaneplatinum II citrate 15 Radiotherapy, Intensity-Modulated 14 atezolizumab 13 Taxes 13 Methods 13 Early Intervention, Educational 13 fludarabine 12 Ipilimumab 12 toripalimab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02482740 2015-06-26

TGOG1005

Buddhist Tzu Chi General Hospital

Phase 2 Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡